Zentynel Frontier Investments
VC Fund
Santiago, Chile
Zentynel Frontier Investments is a VC fund in Santiago focused on Biotechnology and Health Care. Zentynel Frontier is a investment firm.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 61%
- Fund size:
- $4M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Zentynel Frontier Investments invests in
Stages Zentynel Frontier Investments invests in
Countries Zentynel Frontier Investments invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $400k–$6M
- Series A
- $500k–$17M
Investment Focus
Industry
- Biotechnology 8 (44%)
- Health Care 7 (39%)
- Medical 4 (22%)
- Artificial Intelligence 4 (22%)
- Fitness 2 (11%)
Stage
- Seed 7 (39%)
- Series A 5 (28%)
- Venture - Series Unknown 2 (11%)
- Angel 1 (6%)
- Pre-Seed 1 (6%)
Country
- United States 5 (28%)
- Uruguay 2 (11%)
- Argentina 2 (11%)
- Chile 1 (6%)
- Brazil 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Roberto Loehnert
General Partner
|
General Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| NeoCrop Technologies modernizes the breeding of agri-food crops and contributes to the development of new seeds. | $2.8M / Seed / Oct 05, 2026 | ||
| BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment. | $8M / Series A / Jan 12, 2026 | ||
| Axenya leverages the power of data to deliver personalized health, greater control, and cost savings. They design solutions for managing a company's corporate health. | $12M / Series A / Aug 25, 2025 | ||
| Asclepii is a medical device company that specializes in providing healthcare professionals with advanced tools and solutions in the field of regenerative medicine. The company develops innovative products that aim to improve the body's natural healing processes by promoting tissue regeneration and reducing recovery times. Its solutions aredesigned to address various types of wounds, including chronic, acute, and surgical wounds, offering both practical and effective care options. With a commitment to advancing healthcare through technology and research, Asclepii works closely with medical experts to deliver tailored devices that enhance patient outcomes. The company’s focus remains on improving wound care practices, offering healthcare providers effective regenerative medicine tools to aid in healing and tissue repair in clinical settings. | $500K / Seed / Mar 21, 2025 | ||
| Axenya leverages the power of data to deliver personalized health, greater control, and cost savings. They design solutions for managing a company's corporate health. | Nov 25, 2024 | ||
| Nuevos medios de cultivo para capacitación de espermatozoides | $2.6M / Seed / Oct 08, 2024 | ||
| Xeptiva Therapeutics is a veterinary biotechnology company that focuses on developing therapies for chronic inflammation conditions in companion animals. Its main products target chronic pain associated with osteoarthritis and atopic dermatitis in dogs. In addition, the company is developing therapies for the treatment of pain in horses and asthmain cats. Xeptiva's goal is to allow pets to live longer and healthier by targeting the underlying source of many chronic diseases. | $2.5M / Seed / Sep 23, 2024 | ||
| BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment. | $5.9M / Venture - Series Unknown / Jun 06, 2024 | ||
| MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases among other complex diseases. We use a liquid biopsy of whole blood based on RNA sequencing and deep learning looking at all biomarkers in the blood, thus creating a superb biomarker to detect diseases earlier. Our test can be used in continuoustesting both for preventative screening and post-treatment monitoring. Given that it requires only a simple blood sample, it can be administered remotely, anywhere, and costs a fraction of existing diagnostic methods. | $2.7M / Seed / Mar 02, 2023 | ||
| Respira Labs is developing the first wearable device to measure “trapped air,” an early marker of Chronic Obstructive Pulmonary Disease (COPD). No reliable and validated methods currently exist to detect COPD exacerbations in time for early intervention and prevention. By leveraging the power of non-invasive acoustic sensors, audio signalprocessing, machine learning and Acoustic Resonance Index Analysis (ARIA), our device will fundamentally revolutionize COPD management by predicting and preventing attacks at the patient’s home, significantly improving health outcomes and patient quality of life while dramatically lowering health care costs. | $1.5M / Pre-Seed / Dec 21, 2022 | ||
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Zentynel Frontier Investments invest in?
Zentynel Frontier Investments invests primarily in Biotechnology, Health Care and Medical startups, most often at Seed and Series A stage. Most of the 18 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Zentynel Frontier Investments invest in?
Zentynel Frontier Investments typically joins rounds of $400k–$6M at Seed and $500k–$17M at Series A. These are whole funding-round sizes, not Zentynel Frontier Investments's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Zentynel Frontier Investments took part in.
How do I contact Zentynel Frontier Investments?
Public channels for Zentynel Frontier Investments include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Zentynel Frontier Investments?
The team at Zentynel Frontier Investments includes Roberto Loehnert (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
